Is nitroglycerin detrimental in patients with coronary artery ectasia? A case report

S Sanyal1, N Caccavo

  • 1Department of Internal Medicine, Long Island College Hospital, Brooklyn, New York 11201, USA.

Insights

In acute myocardial infarction cases, nitroglycerin worsened ischemia in patients with non-stenotic ectasia, while streptokinase improved symptoms. This suggests a need to identify patients who may experience adverse effects from nitroglycerin.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Pharmacology

Background:

  • Acute myocardial infarction (AMI) management typically involves vasodilators like nitroglycerin.
  • Coronary artery ectasia is a condition characterized by diffuse dilation of coronary arteries without significant stenosis.

Observation:

  • Clinical and electrocardiographic signs of myocardial ischemia unexpectedly worsened during nitroglycerin infusion in a patient with AMI.
  • These ischemic symptoms were rapidly alleviated upon administration of streptokinase.

Findings:

  • Coronary angiography revealed diffuse ectasia with no obstructive coronary artery disease.
  • Nitroglycerin may exacerbate myocardial ischemia in patients with non-stenotic coronary ectasia through specific pathophysiologic mechanisms.

Implications:

  • This finding challenges the routine use of nitroglycerin in all AMI patients, particularly those with underlying ectasia.
  • Further research is warranted to identify patient characteristics and specific pathophysiologic pathways that predispose individuals to nitroglycerin-induced ischemia.
  • Clinical guidelines may need refinement to consider coronary anatomy, such as ectasia, when selecting treatments for AMI.

Related Concept Videos

Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
391
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
283
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
703
Data Reporting and Recording01:24

Data Reporting and Recording

Reporting and recording are crucial in data documentation. The timely, thorough, and accurate documentation of facts is essential when recording patient data. Failure to record findings during an assessment or interpretation of a problem will result in loss of information and make the patient document unreliable. The reader is left with general impressions if the information is not specific. A recording is documenting data of the individual's health information in a traceable, secure, and...
5.5K